---
figid: PMC10218704__ijms-24-08753-g005
pmcid: PMC10218704
image_filename: PMC10218704__ijms-24-08753-g005.jpg
figure_link: /pmc/articles/PMC10218704/figure/F5/
number: Figure 5
figure_title: TAT-AT7 inhibited the VEGFR-2 downstream signaling pathway.
caption: TAT-AT7 inhibited the VEGFR-2 downstream signaling pathway. The expression
  levels of VEGFR-2 and p-VEGFR-2 (A), PLC-γ and p-PLC-γ (B), ERK1/2 and p-ERK1/2
  (C), FAK and p-FAK (D), SRC and p-SRC (E), and AKT and p-AKT (F) in HUVECs treated
  with AT7, TAT, TAT+AT7, and TAT-AT7 in the presence of VEGF-A165 (30 ng/mL), determined
  by Western blot. n = 3
article_title: A Novel Blood–Brain Barrier-Penetrating and Vascular-Targeting Chimeric
  Peptide Inhibits Glioma Angiogenesis
citation: Lu Lu, et al. Int J Mol Sci. 2023 May;24(10).
year: '2023'
pub_date: 2023-5-
epub_date: 2023-5-15
doi: 10.3390/ijms24108753
journal_title: International Journal of Molecular Sciences
journa_nlm_ta: Int J Mol Sci
publisher_name: MDPI
keywords:
- blood–brain barrier
- dual-targeting penetrating peptide
- anti-angiogenesis
- VEGFR-2
- NRP-1
---
